These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5034490)

  • 21. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dynamic function and the osmotic stability of the thrombocytes of children with hemophilia].
    Krasnoshchekova NN
    Probl Gematol Pereliv Krovi; 1974; 19(5):26-7. PubMed ID: 4830585
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of the haemophiliac factor.
    Coutts AM
    Cent Afr J Med; 1997 Sep; 43(9):277-8. PubMed ID: 9509651
    [No Abstract]   [Full Text] [Related]  

  • 24. ["In vivo" platelet adhesiveness measurements using the Borchgrevink technik in children of various age groups].
    Pringsheim W
    Wien Klin Wochenschr; 1968 Feb; 80(8):149. PubMed ID: 5698877
    [No Abstract]   [Full Text] [Related]  

  • 25. The phenotypic heterogeneity of severe hemophilia.
    Jayandharan GR; Srivastava A
    Semin Thromb Hemost; 2008 Feb; 34(1):128-41. PubMed ID: 18393149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Christmas disease associated with prothrombin deficiency and thrombasthenia.
    Alatas H; Iskandar W; Markum AH
    Paediatr Indones; 1969; 9(3):117-22. PubMed ID: 5350280
    [No Abstract]   [Full Text] [Related]  

  • 27. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 28. The value of chrtmogenic activity assay in diagnosis and therapeitic monitoring of hemophlia.
    Adcock DM; Tiefenbacher S; Pruthi RK
    MLO Med Lab Obs; 2017 Feb; 49(2):8, 10, 12-4. PubMed ID: 30005473
    [No Abstract]   [Full Text] [Related]  

  • 29. [HEMOPHILIA, PSEUDOHEMOPHILIA AND THROMBOPATHY].
    LARRAIN C; BANCALARI G
    Rev Med Chil; 1964 Aug; 92():613-24. PubMed ID: 14242013
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hemophilia and nosebleed].
    Timoshenskii VI; Barkagan ZS; Sukhoveeva EI; Tolochko OI
    Vestn Otorinolaringol; 1976; (3):61-5. PubMed ID: 960437
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adhesiveness and aggregation of platelets in hyperthyroidism].
    Girolami A; Fioretti D; Lazzarin M; Brunetti A; Cella G
    Folia Endocrinol; 1972 Feb; 25(1):54-68. PubMed ID: 5067411
    [No Abstract]   [Full Text] [Related]  

  • 32. Acquired platelet defects.
    Ten Cate JW
    Br J Haematol; 1969 Sep; 17(3):300-1. PubMed ID: 5806441
    [No Abstract]   [Full Text] [Related]  

  • 33. [Examining the relationship between the electrophoretic mobility of peripheral red blood cells and their sedimentation rate in patients with hemophilia].
    Iastrubinetskaia OI; Shmarov DA; Sarycheva TG; Popova OV; Kozinets GI
    Klin Lab Diagn; 2009 Nov; (11):46-8. PubMed ID: 20030271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet factor 4(PF4) release during human platelet aggregation in diabetic patients.
    Chmielewski J; Farbiszewski R
    Thromb Diath Haemorrh; 1970 Oct; 24(1):203-5. PubMed ID: 5483960
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of the extracorporal circulation on blood platelet function in men].
    Encke A; Hissen W; Fichter M
    Med Welt; 1972 Jan; 23(1):28-9. PubMed ID: 5060308
    [No Abstract]   [Full Text] [Related]  

  • 37. Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).
    Liu T; Scallan CD; Broze GJ; Patarroyo-White S; Pierce GF; Johnson KW
    Thromb Haemost; 2006 Jan; 95(1):68-76. PubMed ID: 16543964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis.
    Arbini AA; Mannucci PM; Bauer KA
    Thromb Haemost; 1995 Nov; 74(5):1255-8. PubMed ID: 8607105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Platelet aggregation during hypertensive crises induced by a pheochromocytoma].
    Alberola V; Marín J; Aznar J; Pascual Leone A; Valdés M
    Rev Clin Esp; 1970 Jul; 118(2):137-40. PubMed ID: 5486370
    [No Abstract]   [Full Text] [Related]  

  • 40. A new outlook to the qualitative functional platelet disorders.
    Ulutin ON
    New Istanbul Contrib Clin Sci; 1977 Sep; 12(1):75-91. PubMed ID: 609521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.